Luminary Therapeutics, Inc.
PrivateLast Round
Grant
Mar 11, 2025
Total Funding Raised
$59.53M
Company Overview
Luminary Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic cell therapies using its proprietary gamma delta platform to target solid tumors and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luminary Therapeutics, Inc. Comparables
Compare Luminary Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iCell Gene Therapeutics | 82% | |
| Elpis Biopharmaceuticals | 81% | |
| AvenCell | 80% |
Luminary Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 11, 2025 | ||||
| Grant | Jan 27, 2025 | ||||
| Grant | Oct 29, 2024 | ||||
| VC Round | Dec 21, 2022 | ||||
| Series A | Oct 14, 2022 | ||||
SAFE | Oct 14, 2021 |
Luminary Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| ARPA-H | Grant |
| Gopher Angels | Angel, Seed |
| Lunch Pail Ventures | Angel |
| NuFund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
$300K raised from Bio-Techne Corporation, ScaleReady, and Wilson Wolf.
Luminary Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Luminary Therapeutics, Inc.'s valuation, stock price, and market status.
Is Luminary Therapeutics, Inc. a public or private company?
Luminary Therapeutics, Inc. is a private company.
What is the current stock price of Luminary Therapeutics, Inc.?
Luminary Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Luminary Therapeutics, Inc. worth (valuation)?
Valuation information for Luminary Therapeutics, Inc. is not publicly available.
Can I buy Luminary Therapeutics, Inc. stock?
Luminary Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Luminary Therapeutics, Inc.'s last funding round?
Luminary Therapeutics, Inc.'s most recent funding round was Grant on March 11, 2025.
Who are the main investors in Luminary Therapeutics, Inc.?
Investor information for Luminary Therapeutics, Inc. is not publicly disclosed.
Will Luminary Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Luminary Therapeutics, Inc..
How can I track Luminary Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Luminary Therapeutics, Inc.'s secondary market activity and sign up for updates.